5th International conference on Cancer Prevention and Research

Vaccination and immunoprevention have emerged as powerful strategies to reduce cancer incidence by targeting infection-related cancers and boosting immune protection against cancer-causing pathogens. This session highlights advancements in preventive oncology, cancer epidemiology, and healthcare research that demonstrate the impact of vaccines—such as HPV and hepatitis B—in lowering cancer risks worldwide. Discussions will focus on innovative vaccine technologies, public health interventions, and global cancer initiatives aimed at expanding immunization coverage, strengthening cancer prevention strategies, and improving equitable access to lifesaving vaccines in both high-income and resource-limited regions. 

HPV Vaccination and Cervical Cancer Prevention 

Human papillomavirus (HPV) vaccination is a cornerstone of cervical cancer prevention. This sub-topic explores the effectiveness of HPV vaccines, their integration into national immunization schedules, and the role of global cancer initiatives in expanding coverage to underserved populations. 

Hepatitis B Vaccination for Liver Cancer Risk Reduction 

Chronic hepatitis B infection is a major cause of liver cancer worldwide. This sub-topic examines how large-scale vaccination campaigns, supported by public health interventions and preventive oncology programs, have significantly reduced hepatitis B-related cancer incidence and mortality rates. 

Next-Generation Cancer Preventive Vaccines 

Emerging vaccines are being developed to target additional cancer-causing infections and tumor-associated antigens. This sub-topic highlights innovative research in vaccine development, immune-based cancer prevention strategies, and their potential to transform the future landscape of oncology research and immunoprevention. 

Immunoprevention Strategies for Virus-Associated Cancers 

Immunoprevention targets immune responses to infection-induced cancers such as gastric, nasopharyngeal, and anal cancers. This sub-topic discusses the role of vaccines, antibody-mediated approaches, and novel immunotherapies in preventing these cancers and strengthening global cancer initiatives. 

Public Health Campaigns to Improve Vaccine Uptake and Awareness 

Widespread education and outreach are critical for vaccine success. This sub-topic highlights public health interventions, digital awareness campaigns, and community-driven efforts to address misconceptions, increase vaccine acceptance, and improve cancer prevention strategies at the population level. 

Policy Development and Advocacy for Cancer Vaccine Implementation 

Government-backed policies and advocacy play a key role in the success of immunization programs. This sub-topic discusses the formulation of national cancer vaccine policies, funding strategies, and advocacy efforts that support sustainable immunoprevention initiatives globally.